0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Eluting Guidewire Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-38N17766
Home | Market Reports | Health| Medical Devices & Equipment
Global Drug Eluting Guidewire Market Research Report 2024
BUY CHAPTERS

Global Drug Eluting Guidewire Market Research Report 2024

Code: QYRE-Auto-38N17766
Report
August 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Eluting Guidewire Market

Drug eluting guidewire is a medical device that combines the traditional guiding function of the guidewire with the drug elution technology. It mainly consists of two parts: the guidewire body and the drug coating. The guidewire body is usually made of highly elastic materials (such as stainless steel, nickel-titanium alloy, etc.), has good flexibility and pushability, and can smoothly pass through blood vessels or other lumens to reach the lesion site. The drug coating is coated on the surface or specific parts of the guidewire, and these coatings contain therapeutic drugs. During interventional treatment, after the drug eluting guidewire is sent to the lesion site, the drug coating on its surface will gradually contact the blood or tissue and release the drug. These drugs can directly act on the lesion tissue and exert their therapeutic effects, such as inhibiting the proliferation of vascular smooth muscle cells, reducing inflammatory reactions, preventing thrombosis and restenosis, etc. This local administration method has higher targeting and lower side effects than systemic administration.
The global Drug Eluting Guidewire market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Drug Eluting Guidewire is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drug Eluting Guidewire is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Drug Eluting Guidewire include Abbott, Boston Scientific, Medtronic, Svelte Medical Systems, Terumo, Micro-Port Scientific, Aachen Resonance, Biosensors International, Biotronik, Cardionovum, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Eluting Guidewire, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Guidewire.
The Drug Eluting Guidewire market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Drug Eluting Guidewire market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Guidewire manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug Eluting Guidewire Market Report

Report Metric Details
Report Name Drug Eluting Guidewire Market
Segment by Type
  • Drug-coated Guidewire
  • Other
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Boston Scientific, Medtronic, Svelte Medical Systems, Terumo, Micro-Port Scientific, Aachen Resonance, Biosensors International, Biotronik, Cardionovum, eucatech, Eurocor, iVascular, Laborie Medical Technologies, Lepu Medical, Spectranetics, Cook Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug Eluting Guidewire manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug Eluting Guidewire in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug Eluting Guidewire Market report?

Ans: The main players in the Drug Eluting Guidewire Market are Abbott, Boston Scientific, Medtronic, Svelte Medical Systems, Terumo, Micro-Port Scientific, Aachen Resonance, Biosensors International, Biotronik, Cardionovum, eucatech, Eurocor, iVascular, Laborie Medical Technologies, Lepu Medical, Spectranetics, Cook Medical

What are the Application segmentation covered in the Drug Eluting Guidewire Market report?

Ans: The Applications covered in the Drug Eluting Guidewire Market report are Coronary Intervention, Neurointervention, Other

What are the Type segmentation covered in the Drug Eluting Guidewire Market report?

Ans: The Types covered in the Drug Eluting Guidewire Market report are Drug-coated Guidewire, Other

Recommended Reports

Guidewire Markets

Drug Eluting Devices

Coronary & Neuro Devices

1 Drug Eluting Guidewire Market Overview
1.1 Product Definition
1.2 Drug Eluting Guidewire by Type
1.2.1 Global Drug Eluting Guidewire Market Value Comparison by Type (2024-2030)
1.2.2 Drug-coated Guidewire
1.2.3 Other
1.3 Drug Eluting Guidewire by Application
1.3.1 Global Drug Eluting Guidewire Market Value by Application (2024-2030)
1.3.2 Coronary Intervention
1.3.3 Neurointervention
1.3.4 Other
1.4 Global Drug Eluting Guidewire Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Guidewire Revenue 2019-2030
1.4.2 Global Drug Eluting Guidewire Sales 2019-2030
1.4.3 Global Drug Eluting Guidewire Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug Eluting Guidewire Market Competition by Manufacturers
2.1 Global Drug Eluting Guidewire Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug Eluting Guidewire Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug Eluting Guidewire Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Drug Eluting Guidewire, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Eluting Guidewire, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Guidewire, Product Type & Application
2.7 Global Key Manufacturers of Drug Eluting Guidewire, Date of Enter into This Industry
2.8 Global Drug Eluting Guidewire Market Competitive Situation and Trends
2.8.1 Global Drug Eluting Guidewire Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug Eluting Guidewire Players Market Share by Revenue
2.8.3 Global Drug Eluting Guidewire Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Eluting Guidewire Market Scenario by Region
3.1 Global Drug Eluting Guidewire Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug Eluting Guidewire Sales by Region: 2019-2030
3.2.1 Global Drug Eluting Guidewire Sales by Region: 2019-2024
3.2.2 Global Drug Eluting Guidewire Sales by Region: 2025-2030
3.3 Global Drug Eluting Guidewire Revenue by Region: 2019-2030
3.3.1 Global Drug Eluting Guidewire Revenue by Region: 2019-2024
3.3.2 Global Drug Eluting Guidewire Revenue by Region: 2025-2030
3.4 North America Drug Eluting Guidewire Market Facts & Figures by Country
3.4.1 North America Drug Eluting Guidewire Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug Eluting Guidewire Sales by Country (2019-2030)
3.4.3 North America Drug Eluting Guidewire Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Guidewire Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Guidewire Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug Eluting Guidewire Sales by Country (2019-2030)
3.5.3 Europe Drug Eluting Guidewire Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Guidewire Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Eluting Guidewire Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug Eluting Guidewire Sales by Region (2019-2030)
3.6.3 Asia Pacific Drug Eluting Guidewire Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Eluting Guidewire Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Guidewire Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug Eluting Guidewire Sales by Country (2019-2030)
3.7.3 Latin America Drug Eluting Guidewire Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drug Eluting Guidewire Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Guidewire Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug Eluting Guidewire Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug Eluting Guidewire Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Guidewire Sales by Type (2019-2030)
4.1.1 Global Drug Eluting Guidewire Sales by Type (2019-2024)
4.1.2 Global Drug Eluting Guidewire Sales by Type (2025-2030)
4.1.3 Global Drug Eluting Guidewire Sales Market Share by Type (2019-2030)
4.2 Global Drug Eluting Guidewire Revenue by Type (2019-2030)
4.2.1 Global Drug Eluting Guidewire Revenue by Type (2019-2024)
4.2.2 Global Drug Eluting Guidewire Revenue by Type (2025-2030)
4.2.3 Global Drug Eluting Guidewire Revenue Market Share by Type (2019-2030)
4.3 Global Drug Eluting Guidewire Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug Eluting Guidewire Sales by Application (2019-2030)
5.1.1 Global Drug Eluting Guidewire Sales by Application (2019-2024)
5.1.2 Global Drug Eluting Guidewire Sales by Application (2025-2030)
5.1.3 Global Drug Eluting Guidewire Sales Market Share by Application (2019-2030)
5.2 Global Drug Eluting Guidewire Revenue by Application (2019-2030)
5.2.1 Global Drug Eluting Guidewire Revenue by Application (2019-2024)
5.2.2 Global Drug Eluting Guidewire Revenue by Application (2025-2030)
5.2.3 Global Drug Eluting Guidewire Revenue Market Share by Application (2019-2030)
5.3 Global Drug Eluting Guidewire Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Drug Eluting Guidewire Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Drug Eluting Guidewire Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medtronic Drug Eluting Guidewire Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Svelte Medical Systems
6.4.1 Svelte Medical Systems Company Information
6.4.2 Svelte Medical Systems Description and Business Overview
6.4.3 Svelte Medical Systems Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Svelte Medical Systems Drug Eluting Guidewire Product Portfolio
6.4.5 Svelte Medical Systems Recent Developments/Updates
6.5 Terumo
6.5.1 Terumo Company Information
6.5.2 Terumo Description and Business Overview
6.5.3 Terumo Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Terumo Drug Eluting Guidewire Product Portfolio
6.5.5 Terumo Recent Developments/Updates
6.6 Micro-Port Scientific
6.6.1 Micro-Port Scientific Company Information
6.6.2 Micro-Port Scientific Description and Business Overview
6.6.3 Micro-Port Scientific Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Micro-Port Scientific Drug Eluting Guidewire Product Portfolio
6.6.5 Micro-Port Scientific Recent Developments/Updates
6.7 Aachen Resonance
6.7.1 Aachen Resonance Company Information
6.7.2 Aachen Resonance Description and Business Overview
6.7.3 Aachen Resonance Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Aachen Resonance Drug Eluting Guidewire Product Portfolio
6.7.5 Aachen Resonance Recent Developments/Updates
6.8 Biosensors International
6.8.1 Biosensors International Company Information
6.8.2 Biosensors International Description and Business Overview
6.8.3 Biosensors International Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biosensors International Drug Eluting Guidewire Product Portfolio
6.8.5 Biosensors International Recent Developments/Updates
6.9 Biotronik
6.9.1 Biotronik Company Information
6.9.2 Biotronik Description and Business Overview
6.9.3 Biotronik Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biotronik Drug Eluting Guidewire Product Portfolio
6.9.5 Biotronik Recent Developments/Updates
6.10 Cardionovum
6.10.1 Cardionovum Company Information
6.10.2 Cardionovum Description and Business Overview
6.10.3 Cardionovum Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cardionovum Drug Eluting Guidewire Product Portfolio
6.10.5 Cardionovum Recent Developments/Updates
6.11 eucatech
6.11.1 eucatech Company Information
6.11.2 eucatech Description and Business Overview
6.11.3 eucatech Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.11.4 eucatech Drug Eluting Guidewire Product Portfolio
6.11.5 eucatech Recent Developments/Updates
6.12 Eurocor
6.12.1 Eurocor Company Information
6.12.2 Eurocor Description and Business Overview
6.12.3 Eurocor Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Eurocor Drug Eluting Guidewire Product Portfolio
6.12.5 Eurocor Recent Developments/Updates
6.13 iVascular
6.13.1 iVascular Company Information
6.13.2 iVascular Description and Business Overview
6.13.3 iVascular Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.13.4 iVascular Drug Eluting Guidewire Product Portfolio
6.13.5 iVascular Recent Developments/Updates
6.14 Laborie Medical Technologies
6.14.1 Laborie Medical Technologies Company Information
6.14.2 Laborie Medical Technologies Description and Business Overview
6.14.3 Laborie Medical Technologies Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Laborie Medical Technologies Drug Eluting Guidewire Product Portfolio
6.14.5 Laborie Medical Technologies Recent Developments/Updates
6.15 Lepu Medical
6.15.1 Lepu Medical Company Information
6.15.2 Lepu Medical Description and Business Overview
6.15.3 Lepu Medical Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Lepu Medical Drug Eluting Guidewire Product Portfolio
6.15.5 Lepu Medical Recent Developments/Updates
6.16 Spectranetics
6.16.1 Spectranetics Company Information
6.16.2 Spectranetics Description and Business Overview
6.16.3 Spectranetics Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Spectranetics Drug Eluting Guidewire Product Portfolio
6.16.5 Spectranetics Recent Developments/Updates
6.17 Cook Medical
6.17.1 Cook Medical Company Information
6.17.2 Cook Medical Description and Business Overview
6.17.3 Cook Medical Drug Eluting Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Cook Medical Drug Eluting Guidewire Product Portfolio
6.17.5 Cook Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Guidewire Industry Chain Analysis
7.2 Drug Eluting Guidewire Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Guidewire Production Mode & Process
7.4 Drug Eluting Guidewire Sales and Marketing
7.4.1 Drug Eluting Guidewire Sales Channels
7.4.2 Drug Eluting Guidewire Distributors
7.5 Drug Eluting Guidewire Customers
8 Drug Eluting Guidewire Market Dynamics
8.1 Drug Eluting Guidewire Industry Trends
8.2 Drug Eluting Guidewire Market Drivers
8.3 Drug Eluting Guidewire Market Challenges
8.4 Drug Eluting Guidewire Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Drug Eluting Guidewire Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Drug Eluting Guidewire Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Drug Eluting Guidewire Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Drug Eluting Guidewire Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Drug Eluting Guidewire Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Drug Eluting Guidewire Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Drug Eluting Guidewire Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Drug Eluting Guidewire Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Drug Eluting Guidewire, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drug Eluting Guidewire, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drug Eluting Guidewire, Product Type & Application
 Table 12. Global Key Manufacturers of Drug Eluting Guidewire, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug Eluting Guidewire by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Guidewire as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug Eluting Guidewire Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Drug Eluting Guidewire Sales by Region (2019-2024) & (K Units)
 Table 18. Global Drug Eluting Guidewire Sales Market Share by Region (2019-2024)
 Table 19. Global Drug Eluting Guidewire Sales by Region (2025-2030) & (K Units)
 Table 20. Global Drug Eluting Guidewire Sales Market Share by Region (2025-2030)
 Table 21. Global Drug Eluting Guidewire Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Drug Eluting Guidewire Revenue Market Share by Region (2019-2024)
 Table 23. Global Drug Eluting Guidewire Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Drug Eluting Guidewire Revenue Market Share by Region (2025-2030)
 Table 25. North America Drug Eluting Guidewire Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Drug Eluting Guidewire Sales by Country (2019-2024) & (K Units)
 Table 27. North America Drug Eluting Guidewire Sales by Country (2025-2030) & (K Units)
 Table 28. North America Drug Eluting Guidewire Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Drug Eluting Guidewire Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Drug Eluting Guidewire Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Drug Eluting Guidewire Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Drug Eluting Guidewire Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Drug Eluting Guidewire Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Drug Eluting Guidewire Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Drug Eluting Guidewire Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Drug Eluting Guidewire Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Drug Eluting Guidewire Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Drug Eluting Guidewire Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Drug Eluting Guidewire Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Drug Eluting Guidewire Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Drug Eluting Guidewire Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Drug Eluting Guidewire Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Drug Eluting Guidewire Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Drug Eluting Guidewire Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Drug Eluting Guidewire Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Drug Eluting Guidewire Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Drug Eluting Guidewire Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Drug Eluting Guidewire Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Drug Eluting Guidewire Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Drug Eluting Guidewire Sales (K Units) by Type (2019-2024)
 Table 51. Global Drug Eluting Guidewire Sales (K Units) by Type (2025-2030)
 Table 52. Global Drug Eluting Guidewire Sales Market Share by Type (2019-2024)
 Table 53. Global Drug Eluting Guidewire Sales Market Share by Type (2025-2030)
 Table 54. Global Drug Eluting Guidewire Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Drug Eluting Guidewire Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Drug Eluting Guidewire Revenue Market Share by Type (2019-2024)
 Table 57. Global Drug Eluting Guidewire Revenue Market Share by Type (2025-2030)
 Table 58. Global Drug Eluting Guidewire Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Drug Eluting Guidewire Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Drug Eluting Guidewire Sales (K Units) by Application (2019-2024)
 Table 61. Global Drug Eluting Guidewire Sales (K Units) by Application (2025-2030)
 Table 62. Global Drug Eluting Guidewire Sales Market Share by Application (2019-2024)
 Table 63. Global Drug Eluting Guidewire Sales Market Share by Application (2025-2030)
 Table 64. Global Drug Eluting Guidewire Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Drug Eluting Guidewire Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Drug Eluting Guidewire Revenue Market Share by Application (2019-2024)
 Table 67. Global Drug Eluting Guidewire Revenue Market Share by Application (2025-2030)
 Table 68. Global Drug Eluting Guidewire Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Drug Eluting Guidewire Price (US$/Unit) by Application (2025-2030)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Abbott Drug Eluting Guidewire Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Boston Scientific Company Information
 Table 76. Boston Scientific Description and Business Overview
 Table 77. Boston Scientific Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Boston Scientific Drug Eluting Guidewire Product
 Table 79. Boston Scientific Recent Developments/Updates
 Table 80. Medtronic Company Information
 Table 81. Medtronic Description and Business Overview
 Table 82. Medtronic Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Medtronic Drug Eluting Guidewire Product
 Table 84. Medtronic Recent Developments/Updates
 Table 85. Svelte Medical Systems Company Information
 Table 86. Svelte Medical Systems Description and Business Overview
 Table 87. Svelte Medical Systems Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Svelte Medical Systems Drug Eluting Guidewire Product
 Table 89. Svelte Medical Systems Recent Developments/Updates
 Table 90. Terumo Company Information
 Table 91. Terumo Description and Business Overview
 Table 92. Terumo Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Terumo Drug Eluting Guidewire Product
 Table 94. Terumo Recent Developments/Updates
 Table 95. Micro-Port Scientific Company Information
 Table 96. Micro-Port Scientific Description and Business Overview
 Table 97. Micro-Port Scientific Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Micro-Port Scientific Drug Eluting Guidewire Product
 Table 99. Micro-Port Scientific Recent Developments/Updates
 Table 100. Aachen Resonance Company Information
 Table 101. Aachen Resonance Description and Business Overview
 Table 102. Aachen Resonance Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Aachen Resonance Drug Eluting Guidewire Product
 Table 104. Aachen Resonance Recent Developments/Updates
 Table 105. Biosensors International Company Information
 Table 106. Biosensors International Description and Business Overview
 Table 107. Biosensors International Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Biosensors International Drug Eluting Guidewire Product
 Table 109. Biosensors International Recent Developments/Updates
 Table 110. Biotronik Company Information
 Table 111. Biotronik Description and Business Overview
 Table 112. Biotronik Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Biotronik Drug Eluting Guidewire Product
 Table 114. Biotronik Recent Developments/Updates
 Table 115. Cardionovum Company Information
 Table 116. Cardionovum Description and Business Overview
 Table 117. Cardionovum Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Cardionovum Drug Eluting Guidewire Product
 Table 119. Cardionovum Recent Developments/Updates
 Table 120. eucatech Company Information
 Table 121. eucatech Description and Business Overview
 Table 122. eucatech Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. eucatech Drug Eluting Guidewire Product
 Table 124. eucatech Recent Developments/Updates
 Table 125. Eurocor Company Information
 Table 126. Eurocor Description and Business Overview
 Table 127. Eurocor Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Eurocor Drug Eluting Guidewire Product
 Table 129. Eurocor Recent Developments/Updates
 Table 130. iVascular Company Information
 Table 131. iVascular Description and Business Overview
 Table 132. iVascular Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. iVascular Drug Eluting Guidewire Product
 Table 134. iVascular Recent Developments/Updates
 Table 135. Laborie Medical Technologies Company Information
 Table 136. Laborie Medical Technologies Description and Business Overview
 Table 137. Laborie Medical Technologies Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Laborie Medical Technologies Drug Eluting Guidewire Product
 Table 139. Laborie Medical Technologies Recent Developments/Updates
 Table 140. Lepu Medical Company Information
 Table 141. Lepu Medical Description and Business Overview
 Table 142. Lepu Medical Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Lepu Medical Drug Eluting Guidewire Product
 Table 144. Lepu Medical Recent Developments/Updates
 Table 145. Spectranetics Company Information
 Table 146. Spectranetics Description and Business Overview
 Table 147. Spectranetics Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Spectranetics Drug Eluting Guidewire Product
 Table 149. Spectranetics Recent Developments/Updates
 Table 150. Cook Medical Company Information
 Table 151. Cook Medical Description and Business Overview
 Table 152. Cook Medical Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. Cook Medical Drug Eluting Guidewire Product
 Table 154. Cook Medical Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Drug Eluting Guidewire Distributors List
 Table 158. Drug Eluting Guidewire Customers List
 Table 159. Drug Eluting Guidewire Market Trends
 Table 160. Drug Eluting Guidewire Market Drivers
 Table 161. Drug Eluting Guidewire Market Challenges
 Table 162. Drug Eluting Guidewire Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Eluting Guidewire
 Figure 2. Global Drug Eluting Guidewire Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Drug Eluting Guidewire Market Share by Type: 2023 & 2030
 Figure 4. Drug-coated Guidewire Product Picture
 Figure 5. Other Product Picture
 Figure 6. Global Drug Eluting Guidewire Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Drug Eluting Guidewire Market Share by Application: 2023 & 2030
 Figure 8. Coronary Intervention
 Figure 9. Neurointervention
 Figure 10. Other
 Figure 11. Global Drug Eluting Guidewire Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Drug Eluting Guidewire Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Drug Eluting Guidewire Sales (2019-2030) & (K Units)
 Figure 14. Global Drug Eluting Guidewire Average Price (US$/Unit) & (2019-2030)
 Figure 15. Drug Eluting Guidewire Report Years Considered
 Figure 16. Drug Eluting Guidewire Sales Share by Manufacturers in 2023
 Figure 17. Global Drug Eluting Guidewire Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Drug Eluting Guidewire Players: Market Share by Revenue in Drug Eluting Guidewire in 2023
 Figure 19. Drug Eluting Guidewire Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Drug Eluting Guidewire Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Drug Eluting Guidewire Sales Market Share by Country (2019-2030)
 Figure 22. North America Drug Eluting Guidewire Revenue Market Share by Country (2019-2030)
 Figure 23. United States Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Drug Eluting Guidewire Sales Market Share by Country (2019-2030)
 Figure 26. Europe Drug Eluting Guidewire Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Drug Eluting Guidewire Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Drug Eluting Guidewire Revenue Market Share by Region (2019-2030)
 Figure 34. China Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Drug Eluting Guidewire Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Drug Eluting Guidewire Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Drug Eluting Guidewire Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Drug Eluting Guidewire Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Drug Eluting Guidewire by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Drug Eluting Guidewire by Type (2019-2030)
 Figure 53. Global Drug Eluting Guidewire Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Drug Eluting Guidewire by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Drug Eluting Guidewire by Application (2019-2030)
 Figure 56. Global Drug Eluting Guidewire Price (US$/Unit) by Application (2019-2030)
 Figure 57. Drug Eluting Guidewire Value Chain
 Figure 58. Drug Eluting Guidewire Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart